The Consorcio Centro de Investigación Biomédica en Red (CIBER) is a consortium that depends on Instituto de Salud Carlos III (Ministerio de Ciencia e Innovación). The main objective of CIBERDEM (Diabetes and Associated Metabolic Diseases) is to lead the investigative effort of excellence in diabetes and associated metabolic diseases, as well as to accelerate the transfer of results to clinical practice, favouring the flow of knowledge obtained in diabetes to other disciplines and vice versa.
It is formed by 29 reference groups located in 19 institutions in the consortium, including hospitals, universities and research centres of Spain, from 6 Spanish Regions. CIBERDEM works in three corporate programmes:
